Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer.

Harachi, Mio; Masui, Kenta; Cavenee, Webster K; Mischel, Paul S; Shibata, Noriyuki

Harachi, Mio; Masui, Kenta; Cavenee, Webster K; Mischel, Paul S; Shibata, Noriyuki.

Afiliación

Harachi M; Department of Pathology, Division of Pathological Neuroscience, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Masui K; Department of Pathology, Division of Pathological Neuroscience, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Cavenee WK; Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA 92093, USA.
Mischel PS; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Shibata N; Department of Pathology, Division of Pathological Neuroscience, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

Metabolites ; 11(4)2021 Apr 01.

Article en En | MEDLINE | ID: mdl-33916219

Palabras clave

epigenetics; mechanistic target of rapamycin (mTOR) complexes; metabolic reprogramming; microenvironment; protein acetylation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Metabolites Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Metabolites Año: 2021 Tipo del documento: Article País de afiliación: Japón